StopAfib.org interviews Prof. Gregory Lip, of the University of Birmingham (UK)
Find more information on the CHADS2 scoring system, and on Prof. Lip, at:
In this video interview, Dr. Lip discussed the CHA2DS2-VASc tool, which was recently adopted by the European Society of Cardiology Atrial Fibrillation Guidelines for predicting stroke risk in atrial fibrillation.
The CHA2DS2-VASc tool is especially useful for predicting which patients are truly low risk and do not need to be on anticoagulants, and which patients are not low risk and thus should be on anticoagulants such as warfarin (Coumadin) or the newer drugs. The CHA2DS2-VASc tool identifies additional risk factors that were left out of the CHADS2 scoring tool, including being female, age 65-74, or having vascular (heart) disease.
Dr. Lip is a Professor of Medicine at the University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.